Evidence map›Paper›PMID 18708059›Full record

ArticleFEBS letters2008

Cyclophilin-40 has a cellular role in the aryl hydrocarbon receptor signaling.

Tony C Luu, Pompeya Bhattacharya, William K Chan

Open access · greenAbstract read
In one paragraph

Article in FEBS letters, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 47% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Tony C LuuDepartment of Pharmaceutics and Medicinal Chemistry, Thomas J. Long School of Pharmacy and Health Sciences, University of the Pacific, Stockton, CA 95211, USA.
Pompeya Bhattacharya
William K Chan
University of the Pacific · US

Funding

Studies on the Ah Receptors Signaling MechanismR01ES014050 · NIEHS · UNIVERSITY OF THE PACIFIC-STOCKTON · PI CHAN, WILLIAM K · 2006 to 2010
$1.2M
NIEHS NIH HHS R01 ES014050
6 · The paper itself

Abstract

Cyclophilin-40 (CyP40) promotes the formation of the gel shift complex that contains the aryl hydrocarbon receptor (AhR), AhR nuclear translocator (Arnt) and dioxin response element (DRE) using baculovirus expressed proteins. Here we reported that CyP40 plays a role in the AhR signaling. When the CyP40 content in MCF-7 cells is reduced, up-regulation of cyp1a1 and cyp1b1 by 3-methylchloranthrene (3MC) is also reduced, suggesting that CyP40 is essential for maximal AhR function. The CyP40 region containing amino acids 186-215, but not the peptidyl-prolyl cis-trans isomerase and tetratricopeptide repeat domains, is essential for forming the AhR/Arnt/DRE complex. CyP40 is found in the cell nucleus after 3MC treatment and appears to promote the DRE binding form of the AhR/Arnt heterodimer.

Indexed as

Amino Acid SequenceAnimalsAryl Hydrocarbon HydroxylasesAryl Hydrocarbon Receptor Nuclear TranslocatorCell Line, TumorCell NucleusCyclophilinsCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1DimerizationDioxinsElectrophoretic Mobility Shift AssayHumansMethylcholanthrenePeptidyl-Prolyl Isomerase FReceptors, Aryl HydrocarbonAryl Hydrocarbon HydroxylasesAryl Hydrocarbon Receptor Nuclear TranslocatorCyclophilinsCYP1B1 protein, humanCytochrome P-450 CYP1A1Cytochrome P-450 CYP1B1DioxinsMethylcholanthrenePeptidyl-Prolyl Isomerase FReceptors, Aryl Hydrocarbon

Identifiers

PMID18708059
PMCPMC2630774
OpenAlexW1964178419

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.